| __timestamp | Evotec SE | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12404000 | 79838000 |
| Thursday, January 1, 2015 | 18343000 | 121816000 |
| Friday, January 1, 2016 | 18108000 | 117633000 |
| Sunday, January 1, 2017 | 17614000 | 117456000 |
| Monday, January 1, 2018 | 35619000 | 171984000 |
| Tuesday, January 1, 2019 | 58432000 | 257452000 |
| Wednesday, January 1, 2020 | 63945000 | 477643000 |
| Friday, January 1, 2021 | 72200000 | 540684000 |
| Saturday, January 1, 2022 | 76642000 | 651496000 |
| Sunday, January 1, 2023 | 57519000 | 666563000 |
Unleashing insights
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, PTC Therapeutics, Inc. and Evotec SE have demonstrated contrasting strategies in their R&D investments.
From 2014 to 2023, PTC Therapeutics, Inc. has consistently increased its R&D expenses, peaking in 2023 with a 735% increase from 2014. This upward trend underscores the company's aggressive pursuit of new therapies and treatments.
Evotec SE, on the other hand, has shown a more balanced growth in R&D spending, with a 364% increase over the same period. This steady rise reflects a strategic focus on sustainable innovation.
Both companies highlight the diverse approaches within the biotech sector, where innovation is the lifeblood of progress.
Who Prioritizes Innovation? R&D Spending Compared for Novo Nordisk A/S and PTC Therapeutics, Inc.
Comparing Innovation Spending: Bristol-Myers Squibb Company and PTC Therapeutics, Inc.
Vertex Pharmaceuticals Incorporated vs Evotec SE: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs PTC Therapeutics, Inc.
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Evotec SE
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and PTC Therapeutics, Inc.
R&D Spending Showdown: Amneal Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Viking Therapeutics, Inc. or Evotec SE: Who Invests More in Innovation?
Research and Development Expenses Breakdown: PTC Therapeutics, Inc. vs Xenon Pharmaceuticals Inc.
PTC Therapeutics, Inc. vs Evotec SE: Examining Key Revenue Metrics
R&D Insights: How PTC Therapeutics, Inc. and Xencor, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for PTC Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.